NUVB

NUVATION BIO INC.

NUVB · CIK 1811063 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$63M
20202025
Net Income−$205M
20202025
Operating CF−$173M
20202025
Free Cash Flow
20202025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$0.1B$0.0B
Cost of Revenue$0.0B
Gross Profit$0.0B
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense$0.2B$0.1B
Operating Income$-0.2B$-0.6B$-0.1B$-0.1B$-0.1B$-0.0B
Net Income$-0.2B$-0.6B$-0.1B$-0.1B$-0.1B$-0.0B
EPS (Basic)$-0.60$-2.11$-0.35$-0.48
EPS (Diluted)$-0.60$-2.11$-0.35$-0.48

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Total Assets$0.6B$0.5B$0.6B$0.7B$0.8B$0.1B
Current Assets$0.6B$0.5B$0.6B$0.7B$0.8B$0.0B
Cash & Equivalents$0.2B$0.0B$0.0B$0.1B$0.1B$0.0B
Total Liabilities$0.3B$0.1B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.3B$0.5B$0.6B$0.7B$0.7B$0.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.1B$0.1B$0.0B$0.1B$-0.5B$-0.1B
Capital Expenditures
Financing Cash Flow$0.2B$0.0B$0.0B$0.0B$0.6B$0.1B